Virtually no new drugs are being developed for diseases that predominantly affect the poor, according to a report released by Medecins Sans Frontieres (MSF). The report, "Fatal Imbalance" claims among others that from 11 companies surveyed, only one new tuberculosis (TB) drug was brought to the market in the last five years.
Links
[1] https://www.pambazuka.org/author/contributor
[2] https://www.pambazuka.org/taxonomy/term/3286
[3] https://www.pambazuka.org/article-issue/44
[4] https://www.pambazuka.org/taxonomy/term/3285
[5] http://www.pambazuka.org/en/category.php/hivaids/4408